Average Co-Inventor Count = 7.26
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ambrx, Inc. (27 from 113 patents)
27 patents:
1. 12037405 - Anti-CD70 antibody drug conjugates
2. 11993637 - Modified FGF-21 polypeptides with non-naturally encoded amino acids
3. 11786578 - Modified relaxin polypeptides and their uses
4. 11459392 - Anti-CD70 antibody drug conjugates
5. 11439710 - Nucleic acids encoding modified relaxin polypeptides
6. 11420999 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
7. 11311605 - Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides
8. 10961291 - Modified FGF-21 polypeptides and their uses
9. 10954270 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
10. 10751391 - Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid
11. 10702588 - Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain
12. 10377805 - Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses
13. 10253083 - Therapeutic uses of modified relaxin polypeptides
14. 10208123 - Anti-CD70 antibody drug conjugates
15. 9975936 - Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids